[Management of bullous pemphigoid].
Laffitte
E
E
Clinique de Dermatologie, Hôpitaux Universitaires de Genève, Suisse.
Borradori
L
L
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001706:Biopsy; D015153:Blotting, Western; D003937:Diagnosis, Differential; D005455:Fluorescent Antibody Technique; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D018579:Patient Selection; D010391:Pemphigoid, Bullous / Q000175:diagnosis* / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D011379:Prognosis; D013256:Steroids; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D013256:Steroids